Novel research demonstrates a benefit of inhibiting endothelin-2 receptor via {anti-Endothelin BR immunoglobulins. These proteins provide a targeted approach to modulate disease functions fueled by excessive this pathway. In particular, attenuating ETBR is likely to lessen swelling and enhance re… Read More